NTAGI approves SII's Covid-19 vaccine Covovax for 12-17 age group, say sources
The National Technical Advisory Group on Immunization (NTAGI) on Friday approved Serum Institute of India's Covid-19 vaccine Covovax for the 12-17 age group, as per ANI.
Apr 29, 2022, 17:55 PM IST